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Thyroid Hormone Mediation of T cell Proliferation and Survival; Implications for 
Hypothyroidism and Hyperthyroidism. 
Tanya Babiuk-Henry 
 
Hypothyroidism and hyperthyroidism affect 5.9% of Americans over the age of 12. It is 
not known how dysregulation of thyroid hormones such as triiodothyronine (T3), impacts the 
immune system.  
 
A laboratory model system was used to study the interactions between T3 and T cells. 
Jurkat T cells, a leukemic lymphocyte cell line, were cultured in fetal bovine serum (FBS) 
restricted growth media containing four different levels of T3. In order to assess T3 activity on 
proliferation and survival of Jurkat T cells, cell staining and flow cytometry-based techniques 
were used. Adding 10 µg/mL of T3 to culture media increased cell survival rates over a 20 day 
period (p<0.05) and allowed the cells to utilise palmitic acid (PA) as an alternative energy 
source. Adding T3 10 µg/mL significantly increased T cell proliferation over 12 days. While T3 
was essential to T cell survival, it did not significantly affect T cell apoptosis and necrosis rates 
over 12 days. When 2 µM of PA and 10 µg/mL of T3 were added to the cultured cells, T cells 
survived better than with PA alone (p<0.05).  
 
The data collected demonstrates that T3 promotes both the survival and proliferation rate 
of T cells cultured in 1% FBS media due to enhanced use of free fatty acids as fuel. This work 
has implications for how hypothyroidism and hyperthyroidism, impacts the proper functioning of 
the immune system. Low T3 levels could decrease T cell survival and proliferation, while high 
T3 levels may result in changes in T cell substrate utilisation. 
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1.1 Hormones and the endocrine system 
 
Human beings adapt to their environment throughout changing external conditions. In 
order to function properly, the body must detect deviations from optimal conditions and respond 
accordingly to return to normal ranges using chemical signals. Thus, the body has developed a 
finely tuned ability to maintain stable optimal functioning of all the body's systems known as 
homeostasis.  
 
The endocrine system has the essential role of regulating and stabilising the internal 
environment of the body (Maia, Goemann, Meyer, & Wajner, 2011). The regulation of cell 
metabolism, growth, and development is largely controlled by the thyroid hormones (Rhoades & 
Bell, 2013). Thyroid hormones are simple amine-based hormones formed in the thyroid gland, a 
palpable butterfly -shaped structure situated in front of the trachea (Hall & Guyton, 2011). The 
thyroid gland assembles and releases the biologically active hormone triiodothyronine (T3), 
alongside the T3 precursor hormone thyroxine (T4)  (Bianco & Kim, 2006; Olivares et al., 
2012).  Deiodinase type 1 is essential for the conversion of T4 into T3, while type 3 deiodinase 
activity converts T4 and T3 into their inactive form which can then be eliminated from the blood 
(Bianco & Kim, 2006; Maia et al., 2011). The presence of type 3 deiodinase activity is the 
reason, T3 has a half-life of 24 hours in vivo. T3 has a half-life of 12 to 15 hours when added to 
cultured rat neuroglial cells, as these cells actively convert thyroid hormones through deiodinase 
activity (Courtin, Chantoux, & Francon, 1986). The half-life of T3 and uptake of T3 in Jurkat T 
cell culture has not been previously described. 
 
T3 regulates tissue metabolism and gene expression by binding to target cell’s nuclear 
thyroid hormones receptors (Sinha et al., 2012). The thyroid hormones receptors are ligand-
inducible transcription factors, which once bound to T3, will activate gene transcription (Das et 
al., 2006; Yen, 2001), which in turn affects protein synthesis and increases mitochondrial size 
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and numbers (Rhoades & Bell, 2013). Lack of T3 binding to nuclear receptors represses basal 
transcription rates (Ishizuka & Lazar, 2005). 
 
Thyroid hormones have both short-term and long-term effects on their target cells which 
can vary in latency from a few minutes to several days (Wrutniak-Cabello, Casas, & Cabello, 
2001). Long term effects are mediated through nuclear receptor and increased gene transcription, 
while the short-term effect of thyroid hormones are mediated by non-genomic actions (Barreiro 
Arcos et al., 2011). Short term effects of thyroid hormone are due to inner mitochondrial 
membrane carrier adenine nucleotide translocase and can take as little as a few minutes (Sterling, 
1986). T3 has been shown to increase oxygen consumption and mitochondrial oxidative 
phosphorylation in the liver of hypothyroid rats within 30 minutes of an intravenous injection 
(Sterling, 1986). 
 
Thyroid hormone stimulation of mitochondrial gene transcription, basal metabolic rate, 
and protein expression take longer to manifest than changes in oxygen consumption, as these 
require nuclear thyroid hormone receptor activation of mRNA synthesis, phospholipid turnover 
and stimulation of uncoupling protein expression (Wrutniak-Cabello et al., 2001). T3 induced 
increased growth hormone gene transcription in GH3 cells 1 hour after T3 incubation (Yaffe & 
Samuels, 1984). Injection of T3 into euthyroid men, led to an increase in oxygen consumption 
and plasma free fatty acids within 6 hours of an intravenous injection (Rich, Bierman, & 
Schwartz, 1959). A single subcutaneous injection of 20-30 µg T3 lead to an increase in oxygen 
consumption and basal metabolic rate in thyroidectomized rats after a latency period of 20-30 
hours, maximal basal metabolic stimulation occurred around 70 hours after injection (Tata et al., 
1963). Oxygen consumption by hepatocytes of hypothyroid rats increased 24 hours after 
administration of T3, with peak oxygen consumption reached between 72 and 96 hours (Ismail-
Beigi, Bissell, & Edelman, 1979). The addition of 10 nM T3 to confluent fetal rat brown 
adipocytes increased levels of uncoupling protein mRNA synthesis after 24 hours, with mRNA 
levels peaking at 48 hours (Guerra, Roncero, Porras, Fernandez, & Benito, 1996). Treatment of 
hypothyroidism in female rats with T3 (12.5 µg/100g body weight), significantly increased 
mitochondrial mRNA in the liver within 24 hours (Wiesner, Kurowski, & Zak, 1992). Amino 
acid incorporation into mitochondrial protein of thyroidectomized rats increased 36 hours after 
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T3 administration, with peak amino acids uptake occurring 43 to 50 hours after T3 
administration (Roodyn, Freeman, & Tata, 1965). 
 
Additionally, the time lapse in thyroid hormone effect on oxygen consumption and 
metabolism depends on whether T4 or T3 is administered (Myant & Witney, 1967). While two 
injections of T4, given 12 hours apart to healthy rats, noticeably increased oxygen consumption 
after 24-27 hours and led to a significant increase in plasma free fatty acids after 5 days, T3 
injections increased oxygen consumption after 18 hours and significantly increased plasma free 
fatty acid levels after 66 hours (Myant & Witney, 1967).  
 
1.2 Thyroid dysfunction 
 
Thyroid conditions cause an imbalance in the homeostasis of the body's systems which 
may affect an individual's ability to perform normal daily tasks or engage in physical activity 
(Ganapathy & Volpe, 1999; Hackney, Kallman, Hosick, Rubin, & Battaglini, 2012; Kahaly, 
Kampmann, & Mohr-Kahaly, 2002; Kaminsky et al., 2012). Among other things, thyroid 
problems disturb left ventricle function; thus affecting stroke volume and cardiac output, 
ultimately reducing exercise tolerance (Kahaly et al., 2002). Altered thyroid hormone levels have 
been associated with both insulin resistance (Maratou et al., 2009) and metabolic disorders (Chen 
et al., 2016). New research data shows that thyroid conditions are much more common than 
originally thought, with the incidence of thyroid disease increasing with age (Canaris, Manowitz, 
Mayor, & Ridgway, 2000). Most thyroid conditions are caused by an autoimmune condition that 
either over stimulates or destroys the thyroid gland (Rhoades & Bell, 2013; Vanderpump, 2011). 





Hypothyroidism, a condition affecting nearly 4.6% of Americans aged 12 years and older 
(Golden, Robinson, Saldanha, Anton, & Ladenson, 2009), arises when tissues do not have access 
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to sufficient amounts of thyroid hormones. Hashimoto's disease is the most common cause of 
hypothyroidism in the United States (Golden et al., 2009). Additional causes of hypothyroidism 
include the destruction of the thyroid due to surgery or radiation, lack of dietary iodine, 
congenital thyroid malformation and consumption of certain medications (Coelho et al., 2007; 
Masood & Hakeem, 2011; Vanderpump, 2011; Yehuda-Shnaidman, Kalderon, & Bar-Tana, 
2005). The lack of thyroid hormone binding with the thyroid hormone receptors has a repressive 
effect on most gene transcription and can cause the following symptoms: extreme fatigue, 
decreased muscle strength and endurance, decreased basal metabolic rate, cold intolerance, 
formation of a goitre, depression and reduced mental function, problems with reproductive 
systems, hypercholesterolemia and weight gain (Louwerens et al., 2012; Rhoades & Bell, 2013; 
Samuels, 2014). Daily supplementation of levothyroxine, a synthetic thyroxine hormone, is the 




Hyperthyroidism is characterised by excessive amounts of thyroid hormones being 
produced and released into the bloodstream by the thyroid gland. Hyperthyroidism affects 1.3% 
of Americans over 12 years old (Golden et al., 2009). The majority of cases of hyperthyroidism 
are caused by an autoimmune disease called Grave's disease, where a T cell mediated immune 
response attacks the thyroid gland and causes the thyroid gland to become hyperactive, leading 
to a severe overproduction of thyroid hormones  (Mihara et al., 1999). Other causes of 
hyperthyroidism include pituitary or thyroid adenoma and overconsumption of iodine or 
exogenous thyroid medication (Rhoades & Bell, 2013; Topliss & Eastman, 2004). Symptoms of 
hyperthyroidism include: high state of excitability, heat intolerance, profuse sweating, and 
extreme fatigue coupled with inability to sleep, muscle weakness, tachycardia, formation of a 
goitre, weight loss in spite of increased appetite, diarrhea and psychiatric disorders, including 
nervousness, restlessness, irritability, anxiety and sleeplessness (Hall & Guyton, 2011; Rhoades 
& Bell, 2013). Gauthier et al. found that cardiac symptoms caused by autoimmune 
hyperthyroidism could be significantly reduced with thyroidectomy (Gauthier et al., 2016). As 
thyroid hormones have a great impact on the overall regulation of body homeostasis, it is of great 
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importance to understand how thyroid hormones affect the regulation and function of the 
immune system. 
 
1.3 The immune system and T cells 
 
The immune system and the endocrine system interact together to preserve homeostasis. 
The immune system is responsible for protecting us from internal and external threats, such as 
viruses, bacteria, other invading microorganisms, and cancerous cells (Rhoades & Bell, 2013; 
Sompayrac, 2015). To function properly, the immune system must identify potentially dangerous 
invading pathogens while differentiating them from healthy innate tissue cells (Rhoades & Bell, 
2013; Sompayrac, 2015). T cells are essential components of the immune system and cell-
mediated immunity. T cells help regulate active immune responses by releasing cytokines, small 
signalling proteins, which direct the responses of other immune cells (Michalek & Rathmell, 
2010).  T cells are leukocytes, or white blood cells, which mature in the thymus and continuously 
circulate within the secondary lymphoid and peripheral tissues until they come in contact with an 
antigen presenting cell or pathogen (Michalek & Rathmell, 2010; Sompayrac, 2015). Upon 
detecting a foreign particle, T cells divide, exert their function, and die when they are no longer 
needed or able to perform their function appropriately. They may also remain as memory cells to 
help fight off secondary infections with the same pathogen (Green, 2011). 
 
In order to mount a defence against a rapidly dividing pathogen, immune cells must also 
increase their numbers (Hughes & Mehmet, 2003). Activated T cells will release the T cell 
growth factor interleukin 2 which activates the proliferation pathways of the T cell cycle 
(Hughes & Mehmet, 2003). Proliferation is the action by which the cell population increases in 
number through mitosis, thus replacing cells that have died and increasing the number of live T 
cells (Hughes & Mehmet, 2003). 
 
Hyperthyroidism has been linked to increased T cell proliferation (De Vito et al., 2011). 
Klecha et al. found an increase in proliferation responses in lymphocytes of hyperthyroid mice 
compared to euthyroid and hypothyroid mice (Klecha et al., 2006). Administration of T3 to 
hypothyroid mice increased T cell proliferation back toward levels seen in euthyroid mice 
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(Klecha et al., 2006).Thyroid hormone mediated-increases in T cell proliferation are especially 
remarkable in cells with mutated proliferation pathways. Both T3 and T4 cause increased 
proliferation in the human glioma (U-87 MG) cell line (Lin et al., 2009) and have been shown to 
have a growth factor-like effect on T cell lymphomas, leading to increased lymphoma 
proliferation (Cayrol et al., 2015). The proliferation of EL-7 T lymphoma cells was significantly 
increased in hypothyroid mice compared to euthyroid mice 10 days post tumor inoculation (H. 
Sterle et al., 2016). T cell proliferation can be measured using a carboxyfluorescein succinimidyl 
ester (CFSE) intercellular protein dye (Barreiro Arcos et al., 2011; Fulcher & Wong, 1999). The 
fluorescence intensity of the CFSE dye halves each time the cell divides, allowing for the 
quantification of cell proliferation using flow cytometry (Fulcher & Wong, 1999). 
 
1.4 T cell metabolism 
 
Naïve T cells and memory T cells do not require large quantities of energy to support 
their survival (Michalek & Rathmell, 2010). Non-activated cells rely mostly on glucose 
oxidation in the tricarboxylic acid cycle and mitochondrial fatty acid oxidation for their energy 
needs (Michalek & Rathmell, 2010). Once activated, T cells undergo a phase of increased 
growth and proliferation brought on by cytokine signaling (R. Wang & Green, 2012). To 
accumulate enough biomass and energy to undergo proliferation, T cells must have access to a 
substantial amount of adenosine triphosphate (ATP) (Lochner, Berod, & Sparwasser, 2015; 
Michalek & Rathmell, 2010). In order to support their increased need for substrates, activated T 
cells increase their consumption and catabolism of glucose, glutamine and oxygen, while 
simultaneously restricting their use of free fatty acids (R. Wang & Green, 2012).  
 
Production of ATP through fatty acid oxidation occurs most often in the mitochondria of 
rapidly proliferating T cells (Byersdorfer et al., 2013; R. Wang & Green, 2012). Uptake of long-
chain fatty acids into the mitochondria necessitates the conversion of FAs Acyl-CoA groups into 
acylcarnitines (Byersdorfer et al., 2013; Jansen, Cook, Song, & Park, 2000). This conversion is 
catalysed by the enzyme carnitine palmitoyltransferase I (CPT1) which can be 
pharmacologically blocked with the CPT1 irreversible inhibitor etomoxir (Ratheiser et al., 1991). 
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Etomoxir prevents the transformation of long-chain fatty acids into acylcarnitines, therefore 
preventing the uptake of these fatty acids into the inner mitochondrial membrane (Horn, Ji, & 
Friedman, 2004; Kruszynska, Stanley, & Sherratt, 1987). Etomoxir inhibits the oxidation of 
long-chain fatty acids without affecting the oxidation of short-chain or medium-chain fatty acids 
(Rupp, Schulze, & Vetter, 1995; Tutwiler & Ryzlak, 1980). Etomoxir is known to cause ATP 
depletion and decrease the efficiency of the electron transport chain (Hernlund et al., 2008; Pike, 
Smift, Croteau, Ferrick, & Wu, 2011). Etomoxir has also been shown to inhibit the oxidation of 
palmitoyl-CoA and palmitic acid (PA) in hepatic mitochondria of rats (Tutwiler & Ryzlak, 
1980). Concentrations of etomoxir ranging from 100µM to 1mM have been used in cell culture 
to block CPT1 activity and fatty acid oxidation (Byersdorfer et al., 2013; Paumen et al., 1997; 
Pike et al., 2011). 
 
Thyroid hormones play an important role in the regulation of mitochondrial fatty-acid 
oxidation.  T3 increases oxidative metabolism and increase the uptake of fatty acids into hepatic 
mitochondria while increasing lipid autophagy (Liu & Brent, 2010; Sinha et al., 2012). Long-
term T3 treatment has been shown to increase oxidation of fatty acids by increasing the 
expression and activity of CPT1α in rat liver mitochondria, as T3 is essential to the transcription 
of CPT1 mRNA (Jackson-Hayes et al., 2003). CPT1α mRNA levels were decreased by 80% in 
the livers of hypothyroid rats compared to hyperthyroid rats (Mynatt, Park, Thorngate, Das, & 
Cook, 1994). CPT1α enzyme activity was increased in hyperthyroid rats and decreased in 
hypothyroid rats compared to euthyroid rats (Mynatt et al., 1994). 
 
Thyroid hormones also have a vital role in free fatty acid release from human adipose 
tissue (Debons & Schwartz, 1961). Experiments using labelled PA showed that thyroid 
hormones increased both the utilisation and mobilisation of fatty acids (Harlan, Laszlo, 
Bogdonoff, & Estes JR, 1963). Human subcutaneous fat deposits consist of 21 to 30% PA, 
with oleic, palmitoleic and steric acids making up the majority of the rest (Kingsbury, Paul, 
Crossley, & Morgan, 1961). PA is most abundant free fatty acid found in plants and animals 
(Takahashi et al., 2012). PA is often used in cell culture experiments, as it has been shown to be 
less toxic and better tolerated by Jurkat T cells and neutrophil cells than polyunsaturated fatty 
acids (Healy, Watson, & Newsholme, 2003; Lima, Kanunfre, Pompeia, Verlengia, & Curi, 
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2002). Cultured human fibroblast cells have the ability to change their fatty acid composition 
when PA is added to the culture media (Spector, Kiser, Denning, Koh, & DeBault, 1979). 
Although PA is abundantly found in T cell membranes as well as in the serum added to culture 
media, PA levels above 50µM may increase apoptosis in Jurkat T cells due to oxidative stress 
and increased pro-apoptotic Caspase 3 and Caspase 9 activity (Healy et al., 2003; Lima et al., 
2002; Takahashi et al., 2012). Increasing T3 mediated CPT1 activity may decrease PA-induced 
apoptosis since increasing mitochondrial fatty acid oxidation in skeletal muscle cells help 
prevent apoptosis due to PA (Henique et al., 2010). 
 
It is not yet knowing how T3 may affect substrate utilisation in T cell culture in vitro. 
Although thyroid hormones may increase T cells ability to utilise fatty acids to produce ATP, T3 
also lead to a greater utilisation of ATP to maintain normal functions. T3 leads to greater use of 
ATP to maintain proper ion gradients in the sodium-potassium pumps (DeLuise & Flier, 1983). 
T3 also decreases the efficiency of the electron transport chain in the mitochondria due to 
uncoupling proteins, causing proton leakage (Gong, He, Karas, & Reitman, 1997).  
 
1.5 Cell death 
 
Regulation of cell death is essential for the homeostasis of the immune system and 
preventing disease states. Programmed cell death helps control T cell population numbers, 
preventing T cell population atrophy due to too much T cell death and preventing autoimmune 
disorders or formation of cancers due to T cell overcrowding and survival of mutated T cells 
(Michalek & Rathmell, 2010). Pathways for programmed cell death in T cells include apoptosis, 
necrosis and autophagy (Kroemer et al., 2009). T cell apoptosis is closely associated with the cell 
cycle. T cell cycle is essential for T cell proliferation and it allows the cell to undergo mitosis, 
leading to T cell replication (Vermeulen, Van Bockstaele, & Berneman, 2003). During the S-
phase of the cell cycle, the cells genome is duplicated and during the M-phase, the mother cell 
divides into two daughter cells (Pucci, Kasten, & Giordano, 2000). Checkpoints at the G1 and 
G2 positions in cell cycle help prevent the mitosis of genetically damaged or abnormal cells 
(Green, 2011; Hughes & Mehmet, 2003; Pucci et al., 2000). Recognition of DNA damage by 
9 
 
protein kinases at the G1 checkpoint causes the release of caspases leading to the activation of 
the apoptotic pathways (Pucci et al., 2000).  
 
Apoptotic T cells undergo a series of ATP-dependant morphological and biochemical 
changes which eventually lead to cell death including cell shrinkage, condensation, and 
fragmentation of the cell’s nucleus (Ouyang et al., 2012). Early apoptosis causes 
phosphatidylserine to be externalized to the cell surface, while cellular membrane integrity is 
often conserved until the final stages of apoptosis where the cell membrane fragments are 
absorbed by the macrophages in the body (Green, 2011; Hughes & Mehmet, 2003; Kroemer et 
al., 2009). Apoptosis can also be triggered by addition of chemical drugs, high PA 
concentrations, Fas ligand, tumor necrosis factors, lack of growth factors, and viral or bacterial 
infection (Pucci et al., 2000; Takahashi et al., 2012). The apoptotic process is of short duration 
and T cell apoptosis is considered to be a transient state, therefore any measurement of apoptosis 
will only show the percentage of cells undergoing apoptosis at that very moment and not the total 
percent of cells that have undergone apoptosis (Darzynkiewicz & Traganos, 1998).  
 
Necrosis is not dependent on caspases and is a much less regulated process (George et al., 
2004; Ouyang et al., 2012). Necrosis is sometimes due to ATP depletion when cells no longer 
have enough energy to sustain survival (Eguchi, Shimizu, & Tsujimoto, 1997). Cells undergoing 
necrosis will increase in volume, undergo chromatin condensation, swelling of organelles and 
decreased cellular integrity, leading to the rupture of the cell and the release of the cell’s contents 
into the local circulation (George et al., 2004; Green, 2011; Hughes & Mehmet, 2003). Necrosis 
is often caused by the permeabilization of the mitochondrial membrane by excessive reactive 
oxygen species production (Ouyang et al., 2012).   
 
Flow cytometry and vital stains can be used to distinguish between T cells undergoing 
early-stage apoptosis and necrotic cells. Annexin V stains are used to detect cells with 
phosphatidylcholine lipids on their cell surface (Tatsuta et al., 2013). Normally, these lipids are 
found in the interior of the cell membrane, but phosphatidylserine externalizes to the cell surface 
at the onset of apoptosis (Green, 2011; Hughes & Mehmet, 2003). Necrosis can be measured 
with 7-amino-actinomycin D (7AAD) or propidium iodide (PI), as both these vital dyes have a 
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high affinity for DNA (Riccardi & Nicoletti, 2006; Rieger, Nelson, Konowalchuk, & Barreda, 
2011). 7AAD and PI cannot cross the cell membrane and can only bind to the DNA of dead cells 
whose membrane has lost its cellular integrity (Chan, Wilkinson, Paradis, & Lai, 2012; Rieger et 
al., 2011). Early-stage apoptotic cells are positive for annexin V but negative for 7AAD (George 
et al., 2004). Necrotic cells are positive for both stains because the holes in the cell membrane 
allow both dyes to bind their targets. Flow cytometry and cell viability staining cannot 
distinguish between necrotic and late-stage apoptotic cells (George et al., 2004).  
 
1.6 Research on thyroid hormones and T cells  
 
Jurkat T cells have been used extensively in the literature and represent one of the gold 
standards for in vitro T cell research due to their reproducibility and compatibility with 
laboratory techniques (Koziel et al., 2010; Schoene & Kamara, 1999; C. J. Wang et al., 2014). 
Jurkat T cells are an immortal lymphoblastoid cell line originally taken from a patient with T cell 
leukemia. Jurkat T cells are human-derived and are clones of the original cell culture (Kon et al., 
2013) and have a population doubling time of 20.7 hours (Schoene & Kamara, 1999). These cells 
have a gene mutation in the phosphatase and tensin homolog gene causing their proliferation 
pathways to always be turned on (Shan et al., 2000).  
 
Jurkat T cells cultured in optimal conditions with 500nM to 1000nM of T3 had an 
increase in apoptosis promoting proteins in their mitochondria (Yehuda-Shnaidman et al., 2005; 
Yehuda-Shnaidman, Kalderon, Azazmeh, & Bar-Tana, 2010). Apoptosis rates also increased in 
human lymphocytes cultured with T3 and T4 compared to lymphocytes cultured without added 
thyroid hormones (Mihara et al., 1999). However, apoptosis rates were decreased and there was a 
trend towards increased monocyte counts when human subjects had serum T3 concentrations 
above 1.95 nmol/L, these values being in the higher section of the normal physiological range of 
1.49 to 2.60 nmol/L (Hodkinson et al., 2009). Low T3 concentrations were associated with 
higher levels of apoptosis causing tumor necrosis factors in patients with non-thyroidal disease 
(Mooradian, Reed, Osterweil, Schiffman, & Scuderi, 1990). T cells from patients’ with Graves’ 
disease have greater apoptosis rates than T cells from control subjects (Sera et al., 2001). 
Neutrophil cells of hypothyroid patients have a decreased ability to undergo phagocytosis 
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(Palmblad, Adamson, Rosenqvist, Udén, & Venizelos, 1981). Additionally, immune cells 
numbers significantly decreased in animals treated with an antithyroid drug for a week (Csaba, 
Kovács, & Pállinger, 2005).  
 
Research on healthy adult subjects found that thyroid hormone variations within normal 
physiological ranges lead to changes in levels of certain T cell and immune markers (Hodkinson 
et al., 2009). In this study, thyroid hormones increased natural killer cell counts, which are 
known to increase the risk of autoimmune disorders (Miyake & Yamamura, 2007). Ingestion of 
oral T3 was found to increase in the immune marker IL-6 (Mariotti et al., 1992). Alteration in IL-
6 concentrations was also found in subjects with thyrotoxicosis (Bartalena et al., 1994). A 
significant increase in soluble IL-2 receptor levels was found in peripheral blood cells of subjects 
with untreated Graves’ disease and hyperthyroid patients with Hashimoto's thyroiditis 
(Nakanishi, Taniguchi, & Ohta, 1991). T3 administration lead to significantly higher soluble   
IL-2 receptor levels in both subjects in remission from Graves' disease and in normal controls 
(Nakanishi et al., 1991). 
 
In summary, fundamental knowledge of how thyroid hormones affect the cells of the 
immune system and how these two systems work together will help doctors to better treat their 
patients and allow for the creation of better pharmacological guidelines. This knowledge will 
help healthcare providers determine if a patient with a thyroid condition is more or less 











2.0 Rationale and Objectives 
 
The primary purpose of this study is to quantify how different concentrations of T3 affect 
T cell survival and proliferation. The second aim of this study is to differentiate the types of cell 
death T cells undergo in the presence different T3 concentrations. The third aim of this study is 
to assess the effect of T3 on T cell metabolism, by measuring T cell survival and proliferation 
when fatty acids are added to the culture medium. Finally, the fourth aim of this study is to 
measure the effect of blocking mitochondrial fatty acid oxidation on T3 mediated T cell survival. 
 
To our knowledge, no previous study has looked at the thyroid hormone mediated effects 
on Jurkat T cell survival, proliferation and metabolism in such a complete way. T cells were 
measured every day until cell viability in the conditions had decreased to a point where T cells in 
the control condition were considered to be over 90% dead. Measurements were conducted every 
24 hours for the entire life cycle of the cells to ensure the data collected was as complete and 
accurate as possible and that the exact time point of changes in T cell survival, proliferation or 
metabolism could be determined.  No other study has looked at the cumulative effect of T3 and 

















 Aim 1: Measure survival and proliferation of T cells cultured with a hyperthyroid, 
euthyroid and hypothyroid T3 levels compared to control condition using both 
microscopy and flow cytometry staining. 
 
 Aim 2: Determine the levels of early-stage apoptosis and necrosis rates of T cells cultured 
with different levels of T3. 
 
 Aim 3: Assess the effects of PA supplementation on survival and proliferation of Jurkat T 
cells cultured in media containing T3 10 µg/mL compared to a control condition using 
both cell parameter and PI cell staining techniques  
 
 Aim 4: Demonstrate the involvement of T3 on mitochondrial fatty acid oxidation in 




 Hypothesis 1: T3 10 µg/mL will increase T cell survival and increase T cell proliferation 
compared to T cells in the other conditions. 
 
  Hypothesis 2: T3 10 µg/mL will increase apoptosis and decrease necrosis compared to 
the other conditions. 
 
 Hypothesis 3: Supplementing T cells in the T3 10 µg/mL condition with palmitic acid 
will have an increase in survival and increase in proliferation compared to the T cells in 
the control condition. 
 
 Hypothesis 4: Adding etomoxir to T cells in the T3 10 µg/mL condition will negate the 





The overall goal of this project is to determine the effect of T3 levels on survival, 
proliferation, and metabolism of Jurkat T cells. In aim 1, the effects of T3 on T cell survival, 
proliferation, and cell characteristics were measured. Initial T cell counts were done with 
microscopy and trypan blue staining. Trypan blue is a technique where a mixture of cells and 
trypan blue dye is placed into a glass hemocytometer and cells are analysed by microscopy. The 
dye stains the outer cell membrane of live cell blue while it enters the cytoplasm of apoptotic or 
necrotic cells and dyes the whole cell a deep blue (Stoddart, 2011). A miniature grid on the glass 
hemocytometer allows the researcher to count the T cells in each grid section under the 
microscope. If T3 did have an effect on T cell survival and proliferation, it would be captured 
with flow cytometry techniques. T cell proliferation was measured by using CFSE staining and 
measuring mean CFSE emission of live cells using flow cytometry. The fluorescence of the 
CFSE dye allowed for accurate measurement of how many times the cell population had 
undergone proliferation. As each mother cell underwent mitosis, the CFSE dye concentration and 
its emission in the subsequent daughter cells were halved when measured on the flow cytometer 
(Fulcher & Wong, 1999).  The T3 levels used in all the experiments were based on the euthyroid 
physiological range of 0.45 µg/mL to 1.32 µg/mL for total serum T4 (Hollowell et al., 2002). 
Since T4 must be converted into T3 to become biologically active (Olivares et al., 2012) and 
Jurkat T cells do not respond as well to T4 (Appendix A, Figure 12), T3 was used instead of T4. 
Additionally, T3 has a ten to a hundred-fold greater affinity for the thyroid hormones receptor 
than T4 (Visser, 1988). 
 
In aim 2, the early-stage apoptosis and necrosis rates of T cells were measured. Cell death 
was expected to occur as a result of apoptosis, but with the suboptimal growth conditions, 
necrosis was also possible. Flow cytometry was used to determine the rates of apoptosis and 
necrosis in each of the different experimental conditions. Apoptosis rates were measured using 
an annexin V stain which attached to the membrane of cells undergoing early-stage apoptosis 
(Tatsuta et al., 2013).  Since apoptosis is a transient state, measurement of apoptosis with 
Annexin V will only show the percentage of T cells undergoing early-stage apoptosis at that 
exact time and cannot measure to total percentage of cells that have undergone the apoptotic 
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process (Darzynkiewicz & Traganos, 1998). A 7AAD dye which stained the interior of necrotic 
cells was used to determine necrosis rates in each condition (George et al., 2004).  
 
In aim 3, the effects of T3 on the survival, proliferation and cell characteristics of T cells 
cultured in media with T3 and the free fatty acid PA was measured. A dose response was 
conducted in order to find a moderate PA concentration to supplement the T cells with. 50 µM 
was the maximum dose added to T cells since levels above 50 µM have been seen to cause T cell 
death (Takahashi et al., 2012). It was predicted that T3 would allow T cells to increase their 
uptake of fatty acids into the mitochondria and help T cells use PA as an additional source of 
nutrients, leading to increased T cell survival and proliferation rates. T cell survival will be 
measured using live cell gating and propidium iodide (PI) staining. T cell proliferation was 
measured by staining T cells with CFSE. 
 
In aim 4, the effect of adding the CPT1 inhibitor etomoxir on the survival of T cells 
cultured with or without T3 was measured. It was predicted that adding etomoxir would inhibit T 
cell uptake and metabolism of fatty acids. Therefore, negating the T3 mediated increase in T cell 
survival, leading to a sudden decrease in the T3 mediated T cell survival rates. T cell survival 

















3.1 Jurkat T cell and T3 preparation 
 
Jurkat T cells were thawed from a cryogenic vial and cultured in vented flasks with 
Roswell Parks Memorial Institute (RPMI) culture media (Thermo Fisher Scientific, Ottawa, ON) 
with 5% fetal bovine serum (FBS) (Wisent Inc., Saint-Jean-Baptiste, QC) for two weeks, giving 
the cells enough time to recover from the cryogenic storage.  The RPMI culture media contains 2 
mg/mL of glucose supplemented with 1mM L-glutamine and 1 mM pen-strep. 
 
The vented flasks were left in a CO2 incubator at 37⁰ C and at a 5% CO2 concentration 
and atmospheric oxygen levels. No additional oxygen was added to any of the conditions and the 
pH of the culture media was not controlled or measured. The cells were passaged every 2 to 3 
days to ensure that the cells did not become over crowded. For the experiment, the Jurkat T cells 
were grown in RPMI culture media containing 2 mg/mL of glucose supplemented with 1mM L-
glutamine, 1 mM pen-strep. Glucose and fatty acids concentrations in the culture media were 
restricted by only adding 1% FBS to RPMI media, instead of the usual 5 to 10% used to culture 
Jurkat T cells. It is unlikely that there would be enough glucose in the 1% FBS media to prevent 
T cell from starving after a week.  
 
Thyroid hormone media was made by dissolving powdered T3 (Sigma-Aldrich, Oakville, 
ON) in 0.02N NaOH and sterile phosphate buffered saline (PBS) (Wisent Inc., Saint-Jean-
Baptiste, QC) to make a 2000 µg/mL stock which was then diluted into culture media. Four T3 
conditions were analysed: T3 at approximated hypothyroid levels (0.1 µg/mL), T3 at normal 
physiological (euthyroid) levels (1.0 µg/mL), T3 at hyperthyroid levels (10 µg/mL), and a 
control group with no added thyroid hormones. T cells were cultured at an initial concentration 
of 50 000 cells/mL, to help ensure consistency between experiments and decrease overcrowding 
of cells, in flasks containing one of the four previously described conditions. Cells were analysed 
on a daily basis for the entirety of the experiments.  
 
For the preparation of thyroid hormone media protocol, please see Appendix D. 
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3.2 T cell survival and proliferation experiments 
 
Initial cell proliferation and viability were measured using a trypan blue counting 
technique.  T cell survival was measured using the BD Accuri TM C6 flow cytometer (BD 
Biosciences, Mississauga, ON) based on cell size and granularity parameters in addition to 
measuring the fluorescence of every individual cell. T cell proliferation was measured by 
incubating T cells with CFSE (Sigma-Aldrich, Oakville, ON) and measuring mean CFSE 
emission of live cells using flow cytometry.  Software on the flow cytometer allowed for gating 
around specific population subtypes and measurement of the percentages of cells contained in a 
specific subpopulation. 
 
For additional information on flow cytometry analysis, please see Appendix B 
For CFSE staining protocol, please see Appendix E. 
 
3.3 T cell apoptosis and necrosis experiment 
 
In order to quantify whether T3 affected T cell death pathways, flow cytometry and cell 
staining were used to differentiate between apoptotic and necrotic cells. To measure T cell 
necrosis and apoptosis rates, T cells from each experimental condition were analysed by flow 
cytometry after being stained with annexin V PE (eBioscience, Inc. San Diego, CA) to measure 
T cell apoptosis and 7AAD (eBioscience, Inc. San Diego, CA) to measure necrosis.  
 
For 7AAD and annexin V staining protocol, please see Appendix F. 
 
3.4 PA supplementation experiments 
 
PA was added to T cells with and without T3. A dose response to PA (Sigma-Aldrich, 
Oakville, ON) was set up with T cells incubated in 1% FBS with 50 µM, 10 µM, 2 µM, 0.4 µM 
or 0 µM of PA. Cell viability was measured over 10 days. Following the PA dose response 
experiment (Figure 6), a concentration of 2 µM of PA was chosen for PA supplementation 
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experiments. For all the PA supplementation experiments, T cells were cultured over 12 days in 
1% FBS media containing one of the following conditions:  10 µg/mL of T3 with 2 µM of PA 
(T310-PA2), 10 µg/mL of T3 with no added PA (T310-PA0), 2 µM of PA with no added T3 
(T30-PA2) and a control condition (T30-PA0).  
 
For PA preparation protocol, please see Appendix G. 
 
The T3 PA dose response was measured using flow cytometry and cell size and 
granularity parameters.  CFSE staining was used to measure T cell proliferation. T cell survival 
was measured by staining T cells with propidium iodide (PI) (Sigma-Aldrich, Oakville, ON) 
before analysing the cells by flow cytometry 
 
For PI staining protocol, please see Appendix H. 
 
3.5 Etomoxir experiments 
 
Additionally, blocking the uptake of fatty acids into the cells mitochondria was used to 
measure whether fatty acids used as an energy source helped T cells survive in the presence of 
T3. T cells were cultured for 6 days in 1% FBS media containing 10 µg/mL of T3 or no added 
T3.  On the 6th day, etomoxir (Sigma-Aldrich, Oakville, ON) at a concentration of 100 µM 
(Byersdorfer et al., 2013) was added to half of the flasks of each condition. The other flasks 
received an equal volume of PBS. Cells were analysed by flow cytometry for an additional 5 
days. 
 









All data collected by flow cytometry was analysed using Flow Jo Single Cell Analysis 
Software (FlowJo LLC, Ashland, OR). Flow Jo allowed for the gating of T cells and live cells, in 
addition to setting quadrants and bisector limits to distinguish between positively and negatively 
stained cells (Figure 13, Appendix B). Raw values were then exported to Excel, where each 
value was corrected using subtraction of within-subject variation from the group mean according 
to Loftus et al., (Loftus & Masson, 1994). The area under the curve (AUC) was then calculated 
for the duration of the experiment according to Pruessner et al. (Pruessner, Kirschbaum, 
Meinlschmid, & Hellhammer, 2003). AUC, a mathematical calculation based on the calculation 
of the definite integral, is often used in pharmacokinetics to measure total dosage of a drug. AUC 
was used to simplify the analysis of the multiple time points collected and comparing the total 
effect of each condition without forfeiting the accuracy of the values collected (Pruessner et al., 
2003). AUC with respect to ground was calculating by adding half the difference between the y 
values of two days to the y value of the previous day. The sum of daily AUC values was 
calculated for the entire length of the experiment.  
 
 Single factor analysis of variance (ANOVA) was performed using a data analysis 
extension on Excel. If the p-value of the ANOVA was below 0.05, the ANOVA was considered 
significant and a subsequent 2-tailed paired Student’s T-test (T-test) was performed. T-tests were 
considered significant if the p-values were ˂ 0.05. P-values above 0.05 were considered not 
significant (NS). P-values between 0.1 and 0.05 were described as a trend (TR). No power 








4.0 Results  
4.1 Effect of T3 on T cell growth and proliferation 
 
In preliminary experiments, T cells were cultured over 10 days in 1% FBS media 
containing 10 µg/mL T3, 0.1 µg/mL T3 or a control condition with no added T3 (Figure 1).  
Total live T cell counts were measured every 24 hours using the trypan blue counting technique 
to ensure results were as complete and detailed as possible. After day 7, there was a noticeable 
decrease in live T cell numbers in the control and 0.1 µg/mL T3 conditions, while live T cell 
counts in the T3 10 µg/mL condition continued to increase. These experiments suggest that T3 
10 µg/mL helps increase T cell numbers in vitro. The amount of serum used and the choice of 
using T3 over T4 was based on other preliminary experiments presented in appendix A (Figure 
12). The 5-day delay before any thyroid hormone effect on T cell numbers can be seen, is most 
likely due to the latency of T3 activation of the thyroid hormones receptor and the genomic 
changes that follow. In the first few days of the experiment, there is most likely still enough 


















Figure 1. T3 increases Jurkat T cell counts 
 
Figure 1. T cells were cultured in 1% FBS containing media with or without T3. Live cells counts were determined 















4.1.1 T3 and survival 
 
In order to investigate the mechanism leading to increased T cell population numbers, 
experiments were done to measure whether adding T3 10 µg/mL to culture media would help 
increase T cell survival or increase T cell proliferation.  
 
A dose response was conducted over 20 days in media containing 10 µg/mL T3, 1.0 
µg/mL T3, 0.1 µg/mL T3 or a control condition, in order to measure the T3 mediated effect on T 
cell survival until cells in all the conditions had crashed. T cell survival was based on flow 
cytometry gating (see appendix B for gating example). Although the percentage of live cells 
slowly diminished in all the conditions, T cells in the T3 10 µg/mL condition survived longer 
than the cells in the other conditions. The dose response curve showed two distinct phases in cell 
survival over the course of the experiment. There was an initial decline in cell survival which 
leveled off around day 6, followed by a sharp decline in cell survival which lead to the complete 
death of T cells in the T3 0.1 µg/mL and control conditions (Figure 2A). The sharp decline in T 
cell survival is most likely due to the depletion of glucose. Thyroid hormone-mediated increase 
in gene transcription take several days to become apparent, this is the most likely reason there 
does not seem to any great differences in T cell survival for the first 7 days of the experiments. 
To make statistical comparisons, the AUC was calculated for 6 experiments over 20 days (Figure 
2B). The single factor ANOVA performed on the AUC values was considered significant, 
indicating that T3 10 µg/mL promoted an increase in T cell survival compared to the other 
conditions. Subsequent paired two-tailed T-tests were performed and showed a significant 
difference (p<0.02) between all the conditions (Figure 2C).  These results suggest that increased 










Figure 2. T cell survival and dose response to T3 
 
 
Figure 2. T cells were cultured in 1% FBS containing media with or without T3. Live cells were determined by flow 
cytometry using size parameters. A) Data pooled from 7 experiments. B) AUC was calculated for the 6 experiments 








4.1.2 T3 and proliferation 
 
To determine if the T3 mediated increase in T cell survival was due to enhanced 
proliferation rates, T cells were labelled with a proliferation dye and cultured over 12 days in 
media containing 10 µg/mL T3, 1.0 µg/mL T3, 0.1 µg/mL or a control condition. The 
concentration and intensity of the CFSE dye are reduced every time the cell divides, leading to 
an inverse relation between proliferation rates and CFSE emission intensity. Therefore, the lower 
the mean cell fluorescence and cell fluorescence AUC, the more the cells have undergone 
proliferation. The graph depicting T cell proliferation did not show an obvious change in the 
mean CFSE levels (Figure 3A). The AUC was calculated for 4 experiments over 12 days (Figure 
3B). T cells in the control condition had a slightly higher CFSE emission, meaning that T cells in 
this condition had proliferated the least. The single factor ANOVA performed on the corrected 
AUC values was considered significant. Subsequent 2 tailed T-tests were performed and showed 
a small but significant difference in T cell proliferation between some of the conditions (Figure 
3C).  As a result of these significance tests, it was apparent that T cells cultured with T3 10 
µg/mL had a trend towards increased proliferation when compared to the control condition. T 
cells cultured with T3 1.0 µg/mL had a significant increase in T cell proliferation compared to 
cell cultured with T3 0.1 µg/mL (p<0.03) and the control condition (p<0.02). T cells cultured 
with T3 0.1 µg/mL had a significant increase in T cell proliferation compared to T cells in the 














Figure 3. T3 and T cell proliferation 
 
 
Figure 3.  T cells were cultured in media with or without T3. Proliferation was measured each day with CFSE 
staining and flow cytometry. A) Data pooled from 4 experiments. B) AUC was calculated for 4 experiments over 12 






4.2 T3 and cell death 
4.2.1 T cell apoptosis 
 
In order to measure the effect of T3 on T cell death, T cells were analysed after being 
stained with annexin V and 7AAD. T cells undergoing early-stage apoptosis are positively 
stained with annexin V, but negative for 7AAD. Necrotic T cells are positively stained by both 
annexin V and 7AAD while live cells are negative for both dyes. 
 
 To see if apoptosis was affected by adding T3 to culture media, T cells were cultured 
over 12 days in media containing 10 µg/mL T3, 1.0 µg/mL T3, 0.1 µg/mL or a control condition. 
There was no visible difference between the mean apoptosis levels of the measured condition 
(Figure 4A). This curve depicts the percent of cell undergoing apoptosis in the culture and cannot 
be compared with the T cell survival curve seen in Figure 2A, as apoptosis is only one of the 
programmed T cell death pathways measured in this study and apoptosis rates stayed relatively 
low during the entire experiment. AUC was calculated for 3 experiments over 12 days (Figure 
4B). Although the mean apoptosis AUC seemed lower for the control condition compared to the 
cells with added T3, the single factor ANOVA performed on the corrected AUC values was not 
considered significant (Figure 4C). No further statistical tests were performed. Although T cells 
in the control condition seem to have slightly less apoptosis than T cells in the other conditions, 
T3 did not have any significant effect on T cell apoptosis rates and apoptosis rates seemed to 
decrease in all the conditions as the experiments progressed. In conclusion, T3 did not affect T 












Figure 4. T3 and T cell apoptosis 
 
 
Figure 4. T cells were cultured in media with or without T3. Apoptosis was measured each day with flow cytometry 
and cell staining. A) Data pooled from 3 experiments. B) AUC was calculated for 3 experiments over 12 days. C) T-








4.2.2 T cell necrosis 
 
While T3 did not have a significant effect on the apoptosis rates of T cells, T cell necrosis 
rates could still be affected by the presence of T3. Necrotic cells are positive for annexin V and 
positive for 7AAD. T cells were cultured over 12 days in media containing 10 µg/mL T3, 1.0 
µg/mL T3, 0.1 µg/mL T3 or a control condition.  In the line graph showing T cell necrosis rates, 
T3 0.1 µg/mL and the control conditions seemed to have a greater percentage of necrotic cells 
compared to the T3 10 µg/mL and T3 1.0 µg/mL conditions (Figure 5A). This curve depicts the 
percent of necrotic cells in the culture and is the inverse of the curve seen in Figure 2A, where 
the percentage of T cells still alive were depicted in the graph. The AUC was calculated for 3 
experiments over 12 days (Figure 5B). The single factor ANOVA performed on the corrected 
AUC values was considered significant. Subsequent 2 tailed T-tests were performed and showed 
a trend towards decreased T cell necrosis between some of the conditions (Figure 5C). T cells 
cultured with T3 10 µg/mL had a trend towards decreased necrosis when compared to the control 
condition. While there was a trend towards less T cell necrosis, T3 10 µg/mL did not 
significantly decrease T cell necrosis rates. In conclusion, there is a weak trend toward decreased 

















Figure 5. T3 and T cell necrosis 
  
 
Figure 5. T cells were cultured in media with or without T3. Necrosis was measured each day with flow cytometry 
and cell staining. A) Data pooled from 3 experiments. B) AUC was calculated for 3 experiments over 12 days. C) 








4.3 T3 and PA supplementation 
 
Given that T3 increased survival in T cells, but had no effect on apoptosis and only a 
trend towards decreasing necrosis, exogenous PA supplementation was used to study whether the 
presence of added T3 allowed the cells to use fatty acid as another energy choice when glucose 
levels in the media were depleted. The appropriate level of PA was chosen after performing a 
dose-response experiment over 10 days (Figure 6). T cell survival was measured instead of total 
T cell numbers (Figure 1), because the goal of this experiment was to determine which 
concentration of PA were tolerated by or toxic to Jurkat T cells cultures with 1% FBS media. T 
cells were cultured for 10 days with 50 µM, 10 µM, 2 µM, 0.4 µM or no added PA. The T cells 
in the 50 µM PA condition had greatly reduced viability from the first day, this was expected as 
PA 50 µM is the highest concentration tolerated by Jurkat T cells cultured in optimal conditions 
(Lima et al., 2002; Takahashi et al., 2012). The sudden 30 % decrease in T cell survival between 
day 6 and day 7 is most likely due to cell starving from lack from glucose depletion. After 
reviewing the dose response results, 2 µM PA was chosen as the desired PA dosage for the 
following experiments. T cells in the 2 µM PA condition seemed to have slightly greater survival 
rates at almost all the time point during the 10 day experiment. The concentration of PA added to 
the culture media would be considered to be quite low physiologically, as PA concentration in 
the blood in euthyroid subjects are 0.19±0.03mM (190±30µM) and have been reported to be as 
high as 0.49 ±0.10mM (490±100µM) in subjects with non-thyroidal illnesses with thyroid 












Figure 6. PA dose response 
 
Figure 6. T cells were cultured for 10 days in 1% FBS containing media, with 50 µM, 10 µM, 2 µM, 0.4 µM or no 














4.3.1 PA and T cell survival 
 
A detailed dose response was conducted over 12 days in 1% FBS media containing T3 10 
µg/mL + 2 µM PA (T3 10-PA 2), 10 µg/mL T3 (T3 10-PA 0), control + 2 µM PA (T3 0-PA 2) 
and the control condition (T3 0-PA 0). The percentage of live cells slowly diminished in all the 
conditions. T cells in the T3 10-PA 2 and T3 10-PA 0 initially had a slighter percentage of live 
cells, then around day 7, T cell survival stabilised (Figure 7A). The AUC was calculated for 8 
experiments over 12 days. The mean AUC for the T3 10-PA 2 condition was visually greater 
than the AUC for the other conditions (Figure 7B). The single factor ANOVA performed on the 
corrected AUC values was considered significant. Subsequent paired two-tailed T-tests were 
performed and showed a significant increase in T cell survival between some of the conditions 
(Figure 7C). T cells cultured in the T3 10-PA 2 condition had a significant increase in survival 
when compared to the other conditions (p<0.04), suggesting that the addition of PA in the 
presence of T3 helps the cell survive longer. There was no significant difference in survival 























Figure 7.  T cells were cultured in media with or without T3 and with or without 2 µM of PA. Live cells were 
measured with flow cytometry using size parameters. A) Data pooled from 8 experiments. B) AUC was calculated 
for all time point for 8 experiments over 12 days. C)  *p < 0.05, ** p < 0.01, p-value for paired two-tailed T-tests 







4.3.2 PA and T cell proliferation 
 
To determine if the T3 and PA-mediated increase in T cell survival was due to enhanced 
proliferation rates, T cells were labelled with a proliferation dye and cultured over 12 days in 1% 
FBS media containing one of the T3- PA conditions. The line graph depicting T cell proliferation 
did not show any visible change in the mean CFSE levels (Figure 8A). AUC was calculated for 6 
experiments over 12 days (Figure 8B). The single factor ANOVA performed on the corrected 
AUC values was considered significant. Subsequent 2 tailed T-tests were performed and showed 
a significant increase in T cell survival between some of the conditions (Figure 8C). T cells 
cultured with T3 10-PA 2 condition had a significant increase in proliferation compared to the 
cells in the T3 10-PA 0 (p<0.02) and T3 0-PA 0 (p<0.05) conditions. T cells cultured in the T3 
10-PA 2 condition showed a trend towards increased proliferation compared to cells in the T3 0-
PA 0 condition. T cells cultured in the T3 0-PA 2 condition indicated a trend towards increased 
proliferation compared to cells in the T3 0-PA 0 condition. Supplementation with 2 µM PA had a 
trend toward increasing T cell proliferation, suggesting that the T cells were starved of nutrients 























Figure 8.  T cells were cultured in media with or without T3 and with or without 2 µM of PA. Live cells were 
measured by flow cytometry and cell staining. A) Data pooled from 6 experiments. B) AUC was calculated for all 
time points for 6 experiments over 12 days. C) *p < 0.05, p-value for paired two-tailed T-tests performed on the 






4.3.3 PI positive cells 
 
Given the results seen with the PA supplementation experiments, a more stringent cell 
survival experiments were performed using PI. T cell death was measured by growing T cells 
over 12 days in one of the T3 - PA conditions and staining them with PI. T cells positively 
stained with PI were considered dead. T cells in the T3 10-PA 2 and the T3 10-PA 0 conditions 
seemed to have fewer dead T cells compared to the T3 0-PA 2 and T3 0-PA 0 conditions (Figure 
9A). The AUC was calculated for 4 experiments over 12 days. The mean AUC for the T3 0-PA 2 
and T3 0-PA 0 conditions was visually greater than in the other conditions, suggesting that T3 
helped T cells survive better (Figure 9B). The single factor ANOVA performed on the corrected 
AUC values was considered significant. Subsequent 2 tailed T-tests were performed and showed 
a significant increase in T cell survival between some of the conditions (Figure 9C). T cells 
cultured with T3 10-PA 2 condition had significantly less death compared to the cells in the T3 
0-PA 2 (p<0.05) and T3 0-PA 0 (p<0.04) conditions. T cells cultured with T3 10-PA 0 condition 
had significantly less death compared to the cells in the T3 0-PA 2 (p<0.04) and T3 0-PA 0 
(p<0.03) conditions. T cells cultured in the T3 0-PA 2 condition had significantly less death 
compared to the cells in the T3 0-PA 0 condition. There was no significant difference in dead 
cells between the T3 0 -PA 2 and the T3 10-PA 0 conditions, suggesting that T3 has a greater 




















Figure 9.  T cells were cultured in media with or without T3 and with or without 2 µM of PA. Dead cells were 
measured by flow cytometry and PI staining. A) Data pooled from 4 experiments. B) AUC was calculated for 4 







4.4 T3 and etomoxir 
 
In the previous experiments, supplementing T cells with T3 and PA resulted in a small 
but significantly increased T cell survival and proliferation, this was most noticeable as of the 6th 
day of the experiment. This lead to the conclusion that T3 might allow T cells to utilise fatty 
acids as an energy source by increasing fatty acid uptake into the mitochondria and 
mitochondrial fatty-acid oxidation. Utilisation of mitochondrial fatty acid oxidation as an energy 
source was measured by adding etomoxir, a beta-oxidation blocker. T cells were cultured for 6 
days in media containing 10 µg/mL T3 or no added T3 (Figure 10 A). On the 6th day after all the 
conditions were analysed, half of the samples were supplemented with 100 µM of etomoxir, the 
rest of the samples were supplemented with the same volume of PBS (Figure 10 B). Etomoxir 
lead to a sharp decline in live T cells in both the T3 10 µg/mL and the control conditions within 
24 hours. The AUC was calculated for 2 experiments over 12 days (Figure 10C). The AUC 
values for the T3 10 µg/mL appeared greater than the AUC for the other conditions. The single 
factor ANOVA performed on the AUC values was considered significant. Subsequent 2 tailed T-
tests were performed and showed a trend in T cell survival between some of the conditions 
(Figure 10 D). T cells cultured in the control condition showed a trend towards an increased in 
live cells compared to the cells cultured in the control+ etomoxir condition. These results suggest 
that T cells already use beta-oxidation to increase their access to nutrients.  T cells cultured 
within the control + etomoxir had a trend towards decreased survival when compared to the T3 
10 µg/mL and the T3 10 µg/mL+ etomoxir condition. Even though there was a sharp decline in 
live T cells in the T3 10 µg/mL condition after etomoxir was added, the difference in mean AUC 











Figure 10. T3 and etomoxir 
 
 
Figure 10.  T cells were cultured in media with or without T3 and half of the sampled were supplemented with 
etomoxir on the 6th day. Live cells were measured by flow cytometry and cell size parameters. A) Data pooled from 
2 experiments. B) Data pooled from 2 experiments. C) AUC was calculated for 2 experiments. D) *p < 0.05, p-value 











The primary purpose of this project was to measure the effects of T3 on T cell survival 
and proliferation. Additionally, the effect of T3 on the T cell’s ability to utilise fatty acids as an 
energy source in a glucose-restricted environment was studied. This research project is the first 
to characterise the T3 mediated effects on T cell survival and proliferation on a daily basis over 
the course of 12 days. This study is also the first to measure these parameters when T cells are 
supplemented with both T3 and PA.  
 
 5.1 T3 increases T cell proliferation and survival 
 
In the first aim of the study, the role of T3 in T cell survival and proliferation was 
studied. Adding T3 significantly increased T cell survival in the glucose-deprived environment. 
Glucose and fatty acids concentrations in the culture media were restricted by only adding 1% 
FBS to RPMI media, instead of the usual 5 to 10% used to culture Jurkat T cells. It is unlikely 
that there was enough glucose in the 1% FBS media to prevent T cell from starving after a week.  
 
The results of the T3 dose response on T cell survival showed two separate phases to the 
decline in T cell survival. This biphasic process of death may initially be due to the decrease in 
available glucose, and that the second part may be due to the decreasing availability of fatty acid 
as they get used up by the T cells. According to these results, the presence of T3 may allow T 
cells to increase their use of fatty acid as an energy source, therefore allowing T cells to postpone 
death from starvation. As mentioned in the literature review, activated T cells preferentially use 
glucose as an energy substrate, but T3 has been shown to increase fatty acid uptake into 
mitochondria of rats (Jackson-Hayes et al., 2003; R. Wang & Green, 2012).  
 
Although the half-life of T3 in Jurkat T cell culture is not known, T3 has a half-life of 12 
to 15 hours when added to cultured rat neuroglial cells (Courtin et al., 1986). Even if T3 
concentration in the conditions had decreased during the course of the experiment, T3 uptake 
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into the cell would have induced genomic changes in the T cell’s proliferation and metabolic 
rates which would have taken several days to become apparent. This is most likely why there 
was a 5 to 7 day delay before any thyroid hormone effect on T cell numbers, survival or 
proliferation was seen, as the latency of T3 activation of the thyroid hormones receptor and the 
changes in gene transcription of proliferative and metabolic pathways took several days to 
become complete. 
 
The proliferation of T cells was significantly increased in cell cultured in the T3 1.0 
µg/mL condition when compared to the 0.1 µg/mL T3 and the control condition. Proliferation 
was also increased in cells cultured with T3 0.1 µg/mL when compared to cells cultured in the 
control condition. These results suggest that T3 increases T cell numbers by both allowing T 
cells to divide more rapidly and by helping T cells to survive longer, as a T cell which survives 
longer with be able to divide more times than a cell which dies off sooner. The proliferation 
effects of T3 10 µg/mL were relatively small, as there was only about a 5% difference between 
the mean AUC of T cell in the T3 10 µg/mL and the control condition. The progressive increase 
in T cell proliferation combined with the increased in T cell survival rates seen in the T3 10 
µg/mL conditions could significantly increase live T cell counts over time and corroborate the 
exponential increase live T cell population seen in Figure 1.  The T3 mediated increase in Jurkat 
T cell proliferation observed in the previously described experiments are compatible with the 
current published literature as T3 has been shown to increase proliferation of mice lymphocytes, 
human glioma cells and T cell lymphomas (Cayrol et al., 2015; Klecha et al., 2006; Lin et al., 
2009; H. A. Sterle et al., 2014).  
 
These results are consistent with the result of the study by Hodkinson et al., where T3 
concentration in the higher levels of the normal physiological range lead to an increase in 
monocyte counts (Hodkinson et al., 2009). This study by Hodkinson et al. also found an increase 
in neutrophil cell counts and an increase in total memory T cells expression when T4 levels were 
increased. Together with the results of this study, this could mean that subjects with 
hypothyroidism may have altered levels of T cells and other immune cells leading to a 
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potentially compromised immune system, while subjects with hyperthyroidism may have an 
overactive immune system, leading to an increased risk of autoimmunity.  
 
Additionally, the increased T cell proliferation with T3 is consistent with the study by 
Klecha et al., that found an increase in proliferation responses in lymphocytes of hyperthyroid 
mice compared to euthyroid and hypothyroid mice (Klecha et al., 2006). If these results were 
extrapolated to the effect of thyroid hormones in human, a decrease in T cell proliferation and T 
cell survival in hypothyroid subjects could potentially lead to a decreased ability to mount an 
immune defense against pathogens. This could hypothetically increase the risk that the immune 
system of a person with severe hypothyroidism would not be able to mount a proper defense 
against an invading pathogen. 
 
5.2 T3 does not significantly alter T cell early-stage apoptosis and 
necrosis rates 
 
The second aim looked at whether the T3-mediated increase in T cell survival altered T 
cell apoptosis or necrosis rates. This was important because apoptosis is a self-defense 
mechanism whereby cells auto-destruct when infected or become otherwise compromised. The 
experiments showed no significant changes in levels of apoptosis regardless of T3 concentration. 
In these experiments, T3 might not have an effect on apoptosis rates because early-stage 
apoptosis is a transient state and cells that underwent the apoptotic process would later be 
measured as being necrotic or debris once the cell has completely disintegrated (Darzynkiewicz 
& Traganos, 1998). Additionally, since necrosis occurs due to ATP depletion, while apoptosis is 
a highly ATP-dependent process, it is logical that T cells in a nutrient restricted environment 
would preferentially undergo necrosis instead of apoptosis (Darzynkiewicz & Traganos, 1998; 
Eguchi et al., 1997). The findings in this study suggested that apoptosis rates stayed below 5% 
for the entirety of the study while more T cells became necrotic due to ATP depletion as the 
experiment progressed. There was a trend towards decreased necrosis in the T3 10 µg/mL 
condition compared to the control condition seen as of day 7. This could be due to T3 increasing 
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CPT1 transcription and increasing mitochondrial fatty acid oxidation in the T cells, therefore 
increasing the amount of ATP available to the cells. 
 
It is difficult to compare our results on T cells apoptosis levels with other published work, 
as the other studies used different types of cells and used different criteria to define apoptosis. 
There has been much controversy concerning the definition and classification of cell death 
(Kroemer et al., 2009). In this study, T cells with phosphatidylcholine lipids on their cell surface 
(stained with Annexin V) and intact membranes were considered to be apoptotic (not stained 
with 7AAD). Cells that had lost their cellular integrity and were positively stained with 7AAD 
were considered to be necrotic. 
 
The previously mentioned studies reporting an increase in apoptosis promoting protein in 
the mitochondria of Jurkat T cells cultures with 500nM to 1000nM of T3 did not measure 
apoptosis using phosphatidylcholine lipids staining (Yehuda-Shnaidman et al., 2005; Yehuda-
Shnaidman et al., 2010). Instead, these studies relied on measurement of changes in 
mitochondrial membrane potential and permeabilization to define apoptosis and used western 
blotting of lysed T cell to measure pro-apoptosis protein concentrations. Another study which 
mentioned an increase in apoptosis rates in human lymphocytes cultured with thyroid hormones 
used the terminal deoxynucleotidyl transferase-mediated deoxy-UTP nick end labeling assay, 
which measures DNA degradation, to define apoptosis (Mihara et al., 1999). Both the 
mitochondrial membrane potential and the DNA degradation methods do not measure cell in the 
same stage of apoptosis as the Annexin V dye and are better suited to measuring later stages of 
apoptosis. The difference in definition and methodology in measuring cell apoptosis makes it 
difficult to compare the current T cell apoptosis rates to those reported in the published studies 
(Kroemer et al., 2009). 
 
5.3 T3 PA supplementation in the presence of T3 increases T cell 
survival and proliferation 
 
In the first experiments, T3 extended the T cell cultures for up to 20 days. It was unlikely 
that there would be enough glucose to keep the cells alive that long and there was no media 
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change or additional glucose supplementation. This suggested that the T cells were using an 
alternate fuel source to get energy. PA was the most likely factor because it is very abundant in 
the serum, and could be derived from the cell membranes of dying cells. The third aim looked at 
whether adding exogenous PA in the presence of T3 would increase T cell survival and 
proliferation compared to PA supplementation alone. The concentration of PA added to the 
culture media was quite low (2µM), as PA concentration in the blood in euthyroid subjects are 
0.19±0.03mM (190±30µM) and have been reported to be as high as 0.49 ±0.10mM 
(490±100µM) in subjects with non-thyroidal illnesses with thyroid hormone binding inhibitor 
(Chopra et al., 1985). 
 
T cell survival rates were very similar when measured with cell size parameter gating and 
PI staining. Culturing T cells with both T3 and moderate levels of PA increased T cell survival 
significantly compared to T cells cultured without T3. This may be due to T3 increasing 
mitochondrial fatty acid oxidation in T cells and allowing them to use the additional fatty acid as 
an energy source when glucose is scarce. These results are compatible with the current literature 
as T3 has been shown to regulate the metabolism of fatty acids by increasing the transcription 
and activity of the CPT1, the enzyme needed for the uptake of fatty acids into the mitochondrial 
oxidative cycle (Jackson-Hayes et al., 2003; Sinha et al., 2012). 
 
  This could mean that subjects with hypothyroidism may be more reliant on circulating 
glucose and may not be able to use fatty acids as effectively as euthyroid subjects. Additionally, 
T cells cultured with T3 10 µg/mL proliferated quicker than T cells without T3 regardless of PA 
supplementation. Therefore, T3 plays a more important role in T cell proliferation than PA 
supplementation. 
 
Mean CFSE fluorescence and AUC of cell fluorescence were higher in the Figure 8 PA 
and T cell proliferation than in the Figure 3 T3 and T cell proliferation experiment because 
higher initial concentrations of CFSE were used to stain Jurkat T cells at the begging of the PA 
supplementation experiments than in the previous T3 and T cell proliferation experiments. The 
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change in CFSE concentrations used to initially stain T cells and differences in standard error 
may account for the significant difference between the T3 10 µg/mL and control conditions in 
Figure 3C, while the difference in proliferation between the T3 10-PA 0 and control conditions 
in Figure 8C was not considered significant. 
 
5.4 Etomoxir does not significantly affect T cell survival 
 
In the fourth aim, etomoxir was added to T cells as a way to inhibit the T3 mediated 
increase in cell beta-oxidation. Although the addition of etomoxir led to a visible decline in live 
T cells in the T3 10 µg/mL condition, it did not have a statistically significant effect on T cell 
survival. Adding etomoxir did lead to a statistically significant decline in live T cells in the 
control condition. The lack of significance is most likely due to the lack of statistical power. 
Even though the results did not significantly show the importance of mitochondrial fatty acid 
uptake and oxidation on T cell survival, the drastic decrease in live T cells rates does corroborate 
the results of the PA supplementation experiment. This could imply that subjects with decreased 
thyroid hormones levels may not have the ability to use mitochondrial fatty acid oxidation 
compared to euthyroid subjects leading to potentially higher circulating free fatty acid level in 
the blood and a need to carefully monitor blood glucose levels (Chopra et al., 1985). Subjects 
with untreated hypothyroidism may need to alter their diet or regulate their blood glucose levels 




Thyroid hormones are essential to the proper functioning of the immune system. These 
experiments show the impact that T3 has on T cell survival and proliferation, regardless of 
supplementation with PA. Adequate levels of thyroid hormones are essential for the body to 




T3 has a role in both increasing T cell proliferation and decreasing cell death. T3 did not 
have any significant effect on T cell early-stage apoptosis rates measured using Annexin V, 
while showing a trend towards decreasing T cell necrosis rates measured with 7AAD in this 
study. Culturing T cells with both T3 and moderate levels of PA increased T cell survival 
significantly compared to T cells cultured without T3. Blocking the T cell’s uptake of fatty acids 
by inhibiting CPT1 activity with etomoxir could potentially negate the T3 mediated effects on T 
cell survival, but those effects were not statistically significant in this study. 
 
5.6 Limitations and strengths 
 
Jurkat T cells were used for these experiments since they are lymphoblastoid cells and 
have less genetic variability than primary cells. This was a major advantage compared to 
research using primary human blood cells which have substantial person-to-person variability, or 
using rodent cells which do not always reflect an actual human scenario. The Jurkat T cells 
robustness allowed for longer term experiments than would be possible with primary human 
blood cells, allowing experiments to last 10 to 20 days. 
 
 One of the major limitations of using Jurkat T cells is that they constantly proliferate at 
an exponential rate, making it difficult to measure effects on their proliferation. The 
concentration of FBS in the culture media was reduced from the standard 10% to 1% in order to 
decrease the rate of T cell proliferation in this study. The mutation which allows Jurkat T cells to 
proliferate constantly makes them a good model to study the immune system and T cells, as their 
metabolic use of energy substrates is very similar to that of activated T cells. The use of Jurkat T 
cells has allowed for the study the effect of T3 on T cells over a much longer period of time than 
would be possible with primary human blood cells. But the mutation that makes Jurkat T cells so 
useful in cell culture also makes the results of these experiments less physiologically relevant. 
The results collected during these experiments are not directly transferable to the effects of 
thyroid hormones in vivo and should be seen as an extrapolation of the possible effects of 




Glucose levels in the media were not measured throughout the experiments, therefore it is 
not known if glucose levels were completely depleted and T cell starvation due to glucose 
depletion can only be hypothesised. PA concentrations in the media were not measured and the 
amount of PA metabolised by T cells in the different conditions is not known. Oxygen 
consumption by T cells was not measured or controlled and formation of reactive oxygen species 
in the experimental conditions is unknown. Additionally, the pH of the culture media was not 
measured or controlled. Therefore, it is unknown if acidity, oxygen consumption or reactive 
oxygen species played a part in the results collected. 
 
5.7 Future studies 
 
In the future, PA levels in the culture media could be measured using High-Performance 
Liquid Chromatography and compared with initial levels used to supplement the culture media. 
Testing daily PA levels could help determine whether changing levels of PA in the media could 
be due to T cells releasing PA during necrosis or using PA as an energy source. Adding PA to 
the etomoxir experiments could help strengthen the hypothesis that T3 does increase fatty acid 
metabolism in Jurkat T cells. 
 
Further studies could also be conducted on primary human blood cells from healthy 
people, which would more closely mimic in vivo immune system conditions. Conducting the 
same experiments on primary blood cells collected from individuals with untreated 
hypothyroidism and hyperthyroidism, could help measure the long-term effect of T3 of T cell 
survival, proliferation and metabolism in a more physiologically relevant way. 
 
Measuring daily glucose levels in the culture media would help solidify the hypothesis 
that T3 help T cell survive even when glucose levels are depleted. Finally, inhibiting T cell 
uptake of glucose with fasentin (a glucose transport inhibitor) would help measure if T3 
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Appendix A: Preliminary Data 
 
These preliminary experiments were done to optimize the correct serum level at which 
Jurkat T cells would proliferate sub-optimally while not dying off too quickly (Figure 11). 
Preliminary experiments monitoring the effect of T3 on T cell viability (Figure 12) was 
conducted using a trypan-based counting technique. 
 
In preliminary experiments, Jurkat T cells were cultured in culture media containing 
different concentrations of FBS over a period of 8 days to measure a dose response in 
proliferation (Figure 11). At 10% FBS T cell counts were the highest, while cell proliferation at 
1% FBS was roughly intermediate. At 0.1% FBS cells did not proliferate and died. After 8 days, 
there was a noticeable dose response of cell proliferation to the different concentration of FBS 
added to the culture media. The T cells cultured in 10% FBS media were proliferating 
exponentially, while the cell cultures in 0.1% and 0.5% FBS containing media demonstrated 
greatly decreased proliferation. 1% FBS was chosen to be used in all the following experiments 
because Jurkat T cells cultured in 1% FBS culture media still survived well without becoming 















Figure 11. FBS Serum response 
 
Figure 11. T cells were cultured in media containing various levels of FBS. Live cells counts were determined by 


















In preliminary experiments, Jurkat T cells were cultured in different concentrations of 
thyroid hormones for a period of 10 days and their viability was measured using the trypan blue 
counting technique. After day 7, there was a noticeable decrease in the percentage of live cells in 
the control and 0.1 µg/mL of T3 and T4 conditions, while the Jurkat cells in the flasks with 10 
µg/mL T3 continued to survive and the cells in the T4 10 µg/mL condition were slowly dying.  
T3 10 µg/mL seems to have had an effect on Jurkat cell survival rates as compared to the other 
conditions tested. The greater survival rates in the T3 10 µg/mL condition compared to the T4 10 
µg/mL condition are most likely due to that fact that T3 has a ten to hundred-fold higher affinity 
for the thyroid hormones receptor than T4, and T4 must be converted into T3 to become 
biologically active (Visser, 1988). 
 
 
Figure 12. T3 maintains Jurkat T cell viability 
 
Figure 12. T cells were cultured in 1% FBS containing media with or without T3. Live and dead cell counts were 






Appendix B: Flow cytometry analysis 
 
FlowJo Single Cell Analysis Software was used to analyse the data collected by flow 
cytometry. The flow cytometer collects many parameters on each event it detects using two 
lasers for excitation. These parameters include cell size (FSC), cell granularity (SSC) and the 
emission levels of fluorescent dyes that cells were stained with. To differentiate between cellular 
debris and T cells and determine the proportion of live T cells in each condition, gates were 
drawn around events visualised according to their FCS and SSC properties. Live cells are large 
with intermediate granularity; apoptotic cells are smaller in size and have a high granularity, 
necrotic cells are larger with high granularity, debris is small with variable granularity 
(Darzynkiewicz & Traganos, 1998). A rectangular gate was used to distinguish lymphocytes 
from cellular debris. A polygon gate was drawn around live T cells to separate them from dead T 
cells. (Figure 13A) 
 
Proliferation was measured by recording the mean CFSE emission of the events in the 
live cell gate using a histogram (Figure 13B). The flow cytometer measured the fluorescence 
intensity of each cell and displays both the peak and mean emission of each event. 
 
In order to measure apoptosis and necrosis, T cells stained with annexin V and 7AAD 
were represented on a dot plot according to their emission levels for each dye (Figure 13C). 
Quadrants were set according to single stain control, differentiating between positively and 
negatively stained cells. Cellular debris is found in Q1, these events are negative for annexin V 
and positive for 7AAD. Necrotic T cells are found in Q2, they are positive for annexin V and 
positive for 7AAD. T cells undergoing apoptosis are found in Q3, they are positive for annexin V 
and negative for 7AAD. Live T cells are found in Q4, they are negative for annexin V and 
negative for 7AAD. 
 
In the PA supplementation experiments, PI staining was used to distinguish between live 
and dead T cells (Figure 13D). T cells were represented on a histogram according to their PI 
emission levels and a bisector tool was used to split the histogram into two sections: dead cells 
which were positively stained by PI and live cells which were negatively stained.  
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 Figure 13. Flow cytometry analysis 
 
 
Figure 13. A) Live cell gating according to SSC and FCS on a 2 dimensional dot plot B) CFSE overlay comparing 
mean CFSE emission of live cells on day 1 (solid line) and day 4 (dashed line) using histograms C) Quadrants used 
to determine the proportion apoptosis and necrosis based on the emission levels of Annexin V and 7AAD.  D) A 








Appendix C: Secondary data analysis 
 
The flow cytometer quantified the size and granularity of each cell based on the FSC and 
SSC properties of the laser. This flow cytometer measured FSC and SSC of all the cells in 
addition to measuring the fluorescence of every individual cell. FSC refers to the cells size while 
SSC refers to the cells granularity and density. An increase in SSC could indicate that the cell’s 
nucleus is fragmenting and that the cell is dying. 
 
T3 and T cell size 
 
While T cells proliferated slightly faster in the presence of T3, this increase in 
proliferation did not seem to account for the increased T cell survival with T3. T cells were 
cultured over 12 days in 1% FBS media containing 10 µg/mL T3, 1.0 µg/mL T3, 0.1 µg/mL or 
in a control condition (Figure 14A). AUC was calculated for 7 experiments over 12 days (Figure 
14B). The single factor ANOVA performed on the corrected AUC values was considered 
significant. Subsequent 2 tailed T-tests were performed and showed a significant difference in T 
cell size between some of the conditions (Figure 14C).  T cells cultured with T3 10 µg/mL had a 
significantly decreased cell size when compared to the cells in the T3 1.0 µg/mL T3 (p<0.004), 
T3 0.1 µg/mL (p<0.0001) and the control (p<0.002) conditions. T cells cultured with T3 1.0 
µg/mL had a significantly decreased cell size when compared to the cells in the T3 0.1 µg/mL 
(p<0.007) and the control (p<0.007) conditions. T cells cultured with T3 0.1 µg/mL had a trend 
towards decreased cell size when compared to the cells in the control condition. The overall 
decreased Jurkat T cell size is most likely due to the insufficiency of extrinsic growth factors in 
the culture media (Rathmell, Vander Heiden, Harris, Frauwirth, & Thompson, 2000). Since 
keeping an increased biomass necessitates a lot of energy, decreasing cell size may help increase 












Figure 14. T cells were cultured in media with or without T3. FSC was measured each day with flow cytometry 
using size parameters. A) Data pooled from 7 experiments. B) AUC was calculated for 7 experiments. C) *p < 0.05, 







T3 and T cell granularity 
 
As T cells die they become more granular as the cellular membrane and nucleus 
fragment. The SSC parameter was used to analyse changes in T cell granularity. T cells were 
cultured over 12 days in 1% FBS media containing 10 µg/mL T3, 1.0 µg/mL T3, 0.1 µg/mL or a 
control condition (Figure 15A). AUC was calculated for 7 experiments over 12 days (Figure 
15B). The single factor ANOVA performed on the corrected AUC values was considered 
significant. Subsequent 2 tailed T-tests were performed and showed a significant difference in T 
cell granularity between all of the conditions (Figure 15C).  T cells cultured with T3 10 µg/mL 
had a significantly decreased cell granularity when compared to the cells in the T3 1.0 µg/mL 
(p<0.0003), T3 0.1 µg/mL (p<0.004) and the control (p<0.006) conditions. T cells cultured with 
T3 1.0 µg/mL had a significantly decreased cell granularity when compared to the cells in the T3 
0.1 µg/mL (p<0.02) and the control (p<0.02) conditions. T cells cultured with T3 0.1 µg/mL had 
a significantly decreased cell granularity when compared to the cells in the control condition. 
Thus, T3 10 µg/mL caused the lowest levels of cell granularity; while the T cells in the control 
condition had the highest granularity was seen without any T3 supplement. 
 
This increase in cell granularity in the control condition suggests that the cells were 
dying, confirming the results of the T3 dose-response experiment (Figure 2). Taken together with 
the size parameter data, it is not clear how T3 10 µg/mL affects cell death. To address the effects 



















Figure 15. T cells were cultured in media with or without T3. SSC was measured each day with flow cytometry 
using size parameters. A) Data pooled from 7 experiments. B) AUC was calculated for 7 experiments. C) *p < 0.05, 





PA and T cell size 
 
Since adding PA to cells allowed them to survive and proliferate more efficiently, it was 
unknown whether adding PA might have any effect on T cell size due to the increased 
availability of fatty acids in the media. FSC was measured by growing T cells over 12 days in 
one of the T3 and PA conditions. Through the experiment, T cell size diminished for all the 
conditions, but there was no visible size difference between the T3 and PA conditions (Figure 
16A). AUC was calculated for 8 experiments over 12 days. The mean AUC seemed higher in the 
T310-PA0 condition even if the error bars were quite large (Figure 16B). The single factor 
ANOVA performed on the corrected AUC values was not considered significant. No further 



























Figure 16.  T cells were cultured in media with or without T3 and with or without 2 µM of PA. FSC was measured 
with flow cytometry using size parameters. A) Data pooled from 8 experiments. B) AUC was calculated for 8 








PA and T cell granularity 
 
SSC was measured by growing T cells over 12 days in one of the T3 and PA conditions 
AUC was calculated for 8 experiments over 12 days. The was no visual difference in granularity 
between the condition even though the mean SSC levels varied a lot from day to day in the T30-
PA2 and T30-PA0 conditions. The variability in mean SSC levels is probably due to the 
decreased number of live cells in these conditions compared to the T310-PA2 and T310-PA0 
conditions (Figure 17A).  AUC was calculated for 8 experiments over 12 days. The mean SSC 
AUC appeared higher in the T310-PA0 condition compared to the other conditions, suggesting 
that cells most likely to die soon (Figure 17B). The single factor ANOVA performed on the 
corrected AUC values was not considered significant. No further statistical tests were performed 






















Figure 17. PA and cell granularity 
 
 
Figure 17.  T cells were cultured in media with or without T3 and with or without 2 µM of PA. SSC was measured 
with flow cytometry using size parameters. A) Data pooled from 8 experiments. B) AUC was calculated for 8 









Appendix D: Preparing T3 Solutions 
 
How to dissolve T3. 
T3 (3,3’,5-triiodo-L-thyronine), SIGMA, cat # T6397 
The final concentration is going to be 10 g/mL, 1 g/mL or 0.1 g/mL 
1. Measure 5 mg of T3 (in a 50 mL tube) on an analytical balance. 
2. Add 5.51 mL of 0.02N NaOH per 5 mg (recalculate based on how much you measured). 
Vortex solution to completely dissolve T3. 
Note-To make 0.02M NaOH, dilute the 1N NaOH by a factor of 50 (add 1 mL of 1N NaOH to 
49 mL ddH2O), keep the stock in a 50 mL plastic tube at room temperature. 
3. Add 3.49 mL of sterile PBS in the hood. Vortex until thyroid hormone is completely 
dissolved.   
4. Pass solution through syringe filter to make it sterile. 
5. Add 30 mL of sterile PBS, in the hood. 
6. Divide into 10, 4 mL aliquots, freeze at -20°C 
7. Take one 4 mL aliquot, and bring volume to 50 mL of 1% FBS media (with pen-strep and l-
glutamine). 
THIS IS THE 10 g/mL solution 
8. To make the 1 g/mL, take 5 mL of the 10 g/mL solution, and add it to 45 mL of 1% FBS 
media (with pen-strep and l-glutamine). 
9. To make the 0.1 g/mL, take 5 mL of the 1 g/mL solution, and add it to 45 mL of 1% FBS 
media (with pen-strep and l-glutamine). 
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Appendix E: CFSE Staining 
 
Overview: 
1. Prepare T cells and add CFSE to warm serum-free media. 
2. Mix them together and put in water bath 37°C for 7 minutes. 
3. Add RPMI media containing FBS and wash twice. Count cells between washes. 
 
Materials:  
-Stock CFSE is aliquoted about 10 µL/aliquot and stored at -20°C. For best reproducibility use 
aliquot once, do not refreeze. You can refreeze once (mark tube with X) just make sure to check 
the labelling (see below). 
-serum free media RPMI (take an aliquot from a bottle in the fridge) 
-regular serum-containing media (e.g. RPMI 5% FBS, pen-strep, l-glutamine) 
-everything must be kept sterile, keep CFSE wrapped in tinfoil to reduce light exposure 
 
Preparation: 
To begin, turn on the water bath to 37°C, pre-warm your media containers. 
At the beginning, set aside some cells for the negative control for flow cytometry 
 
Labelling:  
The strategy is to suspend cells in warm serum-free media and then add diluted CFSE in warm 
serum-free media.  (Plan ahead: you will lose 30-50% of your cells in the end) 
 Count your cells and spin down the desired number, try to label 5x106 minimum 
 ‘Scratch’ the tube to break pellet. Resuspend them in warm serum-free media so the final 
volume is 2x106 cells /mL e.g.: add 2.5 mL of media to 5x106 cells. 
 Make diluted CFSE by adding concentrated CFSE to a separate tube of warm serum-free 
media.  
 Recommend a 1:20,000 FINAL dilution. E.g. to do this add 1L of CFSE to 10 mL of 
warm serum-free media.  
 Add an equal volume of the diluted CFSE to your cells. E.g. add 2.5 mL of diluted CFSE 
to the cells.  
 Quickly put a cap on and invert several times, put in 37°C water bath for 7 minutes.  
 Take the tube from the water bath, add an equal volume of serum containing media  
 Spin down in a centrifuge. 1500 rpm for 8 minutes at room temp.  
 Scratch pellet, resuspend in serum media, take some for counting, and wash once more 
by centrifuging at1500 rpm for 8 minutes at room temp.  
 Perform a viability count after with trypan while it is spinning. 
 Scratch pellet and resuspend in desired media at desired concentration for the experiment.  
 If using Jurkat cells, just put them in media at about 0.1-0.2 x106 cells/mL 
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Appendix F: 7AAD and Annexin V Staining 
 
MATERIALS 
 Jurkat cells 
 7AAD (GE fridge) 
 Annexin V (GE fridge) 
 Annexin V binding buffer (GE fridge) 
 
PROCEDURE 
 bring a plate from SP to GE 
 keep samples on ice as much as possible 
 split each well into 2 Eppendorf tubes (~0.5x106 per tube) 
 OR- do this in a v-bottom plate and use the plate spinner:  
 Spin down in microfuge Eppendorf tubes, 5 sec using the little table top on the bench in 
GE, flip the switch to make it run and count in your head. 
 Remove the liquid phase 
 add 45 µL PBS click to resuspend 
 Add 5 µL of 7AAD, click tubes to mix 
 put samples on ice for 20 minutes 
 Spin down 0.5x106 cells in microfuge Eppendorf tubes, 5 secs, remove the liquid phase 
 resuspend in 50 µL of Annexin V binding buffer 
 Add 5 µL of Annexin V 
 on ice 30 minutes 
 Do not wash, just add 50 µL of Annexin V binding buffer 















Appendix G: PA Protocol 
 
P0500 Sigma PA 
PA  50 µM, 10 µM, 2 µM, 0.4 µM, 0 µM 
Dissolve PA in ethanol.  
Molecular weight 256.42g/mol 
Solubility 20g/L 
1. Measure 5mg (0.005g) of PA (in a 50 mL tube) on analytical balance. 
2. Add 1.94 mL of ethanol per 5mg (recalculate based on how much you measured). Vortex 
solution to completely dissolve PA. This should make a 10mM stock of PA. 
3. Pass solution through syringe filter to make it sterile. 
4. Divide into 150 µL aliquots, freeze at -20°C 
5. To make 25 mL of 50 µM media add 125 µL of 10 mM stock to 24.875 mL of media. 
6. To make 25 mL of 10 µM media add 5 mL of 50 µM media to 20 mL of media. 
7. To make 25 mL of 2 µM media add 5 mL of 10 µM media to 20 mL of media. 


















Appendix H: PI Staining 
 
MATERIALS 




 Keep samples on ice as much as possible to prevent cells from dying 
 Put an aliquot of each sample into 2 Eppendorf tubes (~0.5x106 cells per tube*) 
 Spin down in table top microfuge Eppendorf tubes for 20 seconds using the little 
benchtop on the bench in GE, flip the switch to make it run and count in your head. 
 Completely decant tube: remove the liquid phase using a pipette without touching the cell 
pellet 
 add 200 µL of PBS, spin down, decant the PBS 
 add 50 µL PBS click the tubes together to resuspend 
 Add 5 µL of PI per sample, click tubes to mix 
 put samples on ice for 20 minutes 
 add 50 µl of PBS 














Appendix I: Etomoxir Protocol 
 
E1905 Sigma (+)-Etomoxir sodium salt hydrate 
Solubility 20mM 
Etomoxir solutions  
Molecular Weight 338.76g/mol 
 Wear protective gear when handling powdered etomoxir. Wear a face shield, lab gloves, 
lab coat and breathing mask. 
 Measure 2.0mg of Etomoxir (in a 50 mL tube) on an analytical balance. 
 Add 1 mL of PBS per 2.0mg (recalculate based on how much you measured). Vortex 
solution to completely dissolve powdered etomoxir.  
 Add 250 µL of dissolved etomoxir stock to etomoxir condition flasks containing 14 mL of 
cells in 1% FBS culture media. This will give you a final etomoxir concentration of 103 
µM. 
 Add 250 µL of PBS to control condition flasks containing 14 mL of cells in 1% FBS 
culture media.  
 
 
 
 
 
 
 
 
 
